Literature DB >> 21965506

Ambulatory oxygen in interstitial lung disease.

D Visca, A Montgomery, A de Lauretis, P Sestini, H Soteriou, T M Maher, A U Wells, E A Renzoni.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21965506     DOI： 10.1183/09031936.00190710

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  18 in total

Review 1.  Current best practice in rehabilitation in interstitial lung disease.

Authors:  Atsuhito Nakazawa; Narelle S Cox; Anne E Holland
Journal:  Ther Adv Respir Dis       Date:  2016-11-15       Impact factor: 4.031

Review 2.  Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age.

Authors:  Jonathon Shaw; Tracey Marshall; Helen Morris; Conal Hayton; Nazia Chaudhuri
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 3.  Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

Authors:  Mirjam J G van Manen; J J Miranda Geelhoed; Nelleke C Tak; Marlies S Wijsenbeek
Journal:  Ther Adv Respir Dis       Date:  2017-01-01       Impact factor: 4.031

4.  A bundled care approach to patients with idiopathic pulmonary fibrosis improves transplant-free survival.

Authors:  Tejaswini Kulkarni; John Willoughby; Maria Del Pilar Acosta Lara; Young-Il Kim; Rekha Ramachandran; C Bruce Alexander; Tracy Luckhardt; Victor J Thannickal; Joao A de Andrade
Journal:  Respir Med       Date:  2016-04-20       Impact factor: 3.415

Review 5.  Ambulatory and short-burst oxygen for interstitial lung disease.

Authors:  Charles Sharp; Huzaifa Adamali; Ann B Millar
Journal:  Cochrane Database Syst Rev       Date:  2016-07-06

6.  Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-users.

Authors:  Mengshu Cao; Frederick S Wamboldt; Kevin K Brown; Jonathon Hickman; Amy L Olson; Joshua J Solomon; Jeffrey J Swigris
Journal:  Multidiscip Respir Med       Date:  2015-11-30

7.  Protocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis.

Authors:  Amanda Belkin; Kaitlin Fier; Karen Albright; Susan Baird; Brenda Crowe; Linda Eres; Marjorie Korn; Leslie Maginn; Mark McCormick; Elisabeth D Root; Thomas Vierzba; Frederick S Wamboldt; Jeffrey J Swigris
Journal:  BMC Pulm Med       Date:  2014-11-01       Impact factor: 3.317

8.  Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional Analysis.

Authors:  Camille Rolland-Debord; Stephanie Fry; Jonathan Giovannelli; Carole Langlois; Nicolas Bricout; Bernard Aguilaniu; Agnes Bellocq; Olivier Le Rouzic; Stephane Dominique; Alain Delobbe; Geraldine François; Abdellatif Tazi; Benoit Wallaert; Cecile Chenivesse
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

9.  Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.

Authors:  Dina Visca; Vicky Tsipouri; Letizia Mori; Ashi Firouzi; Sharon Fleming; Morag Farquhar; Elizabeth Leung; Toby M Maher; Paul Cullinan; Nick Hopkinson; Athol U Wells; Winston Banya; Jennifer A Whitty; Huzaifa Adamali; Lisa G Spencer; Piersante Sestini; Elisabetta A Renzoni
Journal:  Trials       Date:  2017-04-28       Impact factor: 2.279

10.  Informal caregivers experience of supplemental oxygen in pulmonary fibrosis.

Authors:  Bridget A Graney; Frederick S Wamboldt; Susan Baird; Tara Churney; Kaitlin Fier; Marjorie Korn; Mark McCormick; Thomas Vierzba; Jeffrey J Swigris
Journal:  Health Qual Life Outcomes       Date:  2017-07-01       Impact factor: 3.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.